MedPath
NMPA Approval

Beraprost Sodium Sustained-release Tablets

国药准字HJ20220067

July 26, 2022

Drug Information

贝前列素钠缓释片

片剂

60μg

化学药品

July 26, 2022

July 25, 2027

Company Information

Applicant Company

1-1, Nihonbashi Muromachi 2-chome, Chuo-ku, Tokyo 103-8666, JAPAN

Manufacturing Company

toray industries, inc. mishima plant

4845, Mishima Shizuoka 411-8652, JAPAN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

贝前列素钠缓释片 - NMPA 批准文号 | MedPath